Japanese pharma Eisai slides 4% despite FDA approval for Alzheimer's drug
July 07, 2023 at 06:00 AM EDT
Leqembi is the first Alzheimer's antibody treatment to receive full FDA approval.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|